Manufacturer record
Ridley Lifescience Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
4 batches manufactured by Ridley Lifescience Pvt. Ltd (Delhi) were declared Not of Standard Quality between April 2022 and August 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: RT230545, Ciprofloxacin Tablets IP 500 mg (exp Jun 2026). State Drugs Testing Laboratory, Govt. of Tripura, Agartala (CDSCO lab) found it not of standard quality: Assay & Dissolution. Listed in the August 2025 alert.
Records by type
4 records linked to Ridley Lifescience Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Ciprofloxacin Tablets IP 500 mg | Batch RT230545Mfg Jul 2023 · Exp Jun 2026 | Assay & DissolutionAssay | State Drugs Testing Laboratory, Govt. of Tripura, AgartalaCDSCO lab | Aug 2025 |
| PHENIRAMINE MALEATE TABLETS IP (APVIL) | Batch APV-2001Mfg Dec 2020 · Exp Nov 2023 | Description, Uniformity of Weight and AssayAssay | CDTL HyderabadCDSCO lab | Feb 2023 |
| Misoprostol Tablets I.P. 200 mcg | Batch RT220304Mfg Mar 2022 · Exp Feb 2024 | AssayAssay | CDL KolkataCDSCO lab | Jan 2023 |
| Ampicillin Capsules IP | Batch AMI-1901Mfg Jul 2019 · Exp Jun 2022 | Assay and MisbrandedAssay | RDTL GuwahatiState lab | Apr 2022 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.